NCT06494202

Brief Summary

The goal of this clinical trial is to systemize and hierarchize a rehabilitation program for the Brazilian Unified Health System in patients with stroke above 18 years of age and of both sexes. The main question it aims to answer is:

  • Do patients with ischemic first episode of stroke have central nervous systems consequences due to peripheral and central nervous system sensibilization?
  • Can stroke patients benefit from a systemized and hierarchized rehabilitation program with desensibilization interventions combined with multidisciplinary and educational programs? We will randomize 60 patients, 30 in each study arm. Researchers will compare the intervention group with an active control whose treatment is the institutional conventional program to see if innovative desensibilization strategies yield superior results. Authors will also investigate the role of genetic polymorphism and ancestrality in the outcome measures. Participants will undertake an innovative or conventional rehabilitation program, according to the randomization.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Oct 2024Dec 2026

First Submitted

Initial submission to the registry

July 2, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 10, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

2.2 years

First QC Date

July 2, 2024

Last Update Submit

July 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Motor recovery

    Motor recovery measured with Fugl-Meyer Assessment (FMA), ranging from 0 to 100 for upper and lower extremities combined. Higher scores mean better outcome.

    Change from baseline to six weeks of intervention.

Secondary Outcomes (9)

  • Functional independence

    Change from baseline to six weeks of intervention.

  • Muscle strength

    Change from baseline to six weeks of intervention.

  • Upper extremity recovery

    Change from baseline to six weeks of intervention.

  • Spasticity reduction

    Change from baseline to six weeks of intervention.

  • Gait recovery

    Change from baseline to six weeks of intervention.

  • +4 more secondary outcomes

Other Outcomes (15)

  • Physical Activity

    Baseline.

  • Postural control

    Change from baseline to six weeks of intervention.

  • Nutritional status

    Baseline.

  • +12 more other outcomes

Study Arms (2)

Conventional rehabilitation program

ACTIVE COMPARATOR

Conventional rehabilitation intervention with multidisciplinary team (medical services, physiotherapy, occupational therapy, physical education, psychology, nutrition, social service, speech therapy, and nurse) delivered during four to six weeks of intensive in-patient program

Other: Conventional rehabilitation program.

Innovative rehabilitation program

EXPERIMENTAL

Conventional rehabilitation intervention with multidisciplinary team (medical services, physiotherapy, occupational therapy, physical education, psychology, nutrition, social service, speech therapy, and nurse) delivered during four to six weeks of intensive in-patient program combined with innovative medical therapies (laser therapy, radial extracorporeal shockwaves therapy, focused extracorporeal shockwaves therapy, segmentary desensibilization with lidocaine, functional electrical stimulation - FES).

Other: Innovative rehabilitationOther: Conventional rehabilitation program.

Interventions

Conventional rehabilitation program associated with innovative therapies.

Innovative rehabilitation program

Conventional rehabilitation program

Conventional rehabilitation programInnovative rehabilitation program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical and radiological (magnetic resonance or tomography) diagnosis of ischemic stroke;
  • Single episode of stroke;
  • Clinical stability according to medical assessment;
  • Time since stroke onset no longer than 24 months;
  • Capacity to understand the study procedures;
  • Eligible to be admitted to hospitalization at the institute where the study will be conducted
  • Agree to sign the Informed Consent Form (ICF).

You may not qualify if:

  • Presence of psychiatric disorders;
  • Presence of subarachnoid hemorrhage;
  • Presence of intracerebral hemorrhage;
  • Presence of neuromuscular disorders;
  • Presence of other neurological diseases or brain neoplasm;
  • Presence of cognitive disorders measured with Montreal Cognitive Assessment (MoCA), scores below 20 points;
  • Presence of systemic arterial hypertension (systolic blood pressure ≥ 185mmHg or diastolic blood pressure ≥ 110 mmHg).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Medicina Física e Reabilitação (IMREA-FMUSP)

São Paulo, 04101-300, Brazil

Location

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Marta Imamura, Professor

    Instituto de Medicina Física e Reabilitação - FMUSP

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Different collaborators will be care providers and outcomes assessors.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 2, 2024

First Posted

July 10, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 31, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Study data will be made available under reasonable request after publication. Data will include de-identified participant data and the data dictionary. Requests can be submitted to the corresponding author. Request will be analyzed and ethical and legal implications of data sharing will be considered. Data will be shared after consent of study participants Brazil is under Brazilian General Data Protection Law (LGPD, English translation) and all shared data will require participants prior consent.

Time Frame
After publication under reasonable request.
Access Criteria
Reasonable request and participants prior consent.

Locations